EARIP
European Asthma Research and Innovation Partnership
| Coordinatore | Asthma UK
Organization address
address: "Summit House, Wilson Street 70" contact info |
| Nazionalità Coordinatore | United Kingdom [UK] |
| Sito del progetto | http://earip.eu/ |
| Totale costo | 778˙764 € |
| EC contributo | 500˙000 € |
| Programma | FP7-HEALTH
Specific Programme "Cooperation": Health |
| Code Call | FP7-HEALTH-2013-INNOVATION-1 |
| Funding Scheme | CSA-SA |
| Anno di inizio | 2013 |
| Periodo (anno-mese-giorno) | 2013-09-01 - 2016-08-31 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 |
Asthma UK
Organization address
address: "Summit House, Wilson Street 70" contact info |
UK (London) | coordinator | 175˙103.00 |
| 2 |
EUROPEAN FEDERATION OF ASTHMA &ALLERGY ASSOCIATIONS IDEELL FORENING
Organization address
city: Brussels contact info |
BE (Brussels) | participant | 67˙000.00 |
| 3 |
IMPERIAL COLLEGE OF SCIENCE, TECHNOLOGY AND MEDICINE
Organization address
address: SOUTH KENSINGTON CAMPUS EXHIBITION ROAD contact info |
UK (LONDON) | participant | 55˙212.00 |
| 4 |
UNIVERSITY OF SOUTHAMPTON
Organization address
address: Highfield contact info |
UK (SOUTHAMPTON) | participant | 48˙685.00 |
| 5 |
FUNDACION PARA LA FORMACION E INVESTIGACION SANITARIAS DE LA REGION DE MURCIA
Organization address
address: CALLE LUIS FONTES PAGAN 9 contact info |
ES (MURCIA) | participant | 40˙000.00 |
| 6 |
KAROLINSKA INSTITUTET
Organization address
address: Nobels Vag 5 contact info |
SE (STOCKHOLM) | participant | 40˙000.00 |
| 7 |
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS
Organization address
address: CHRISTOU LADA 6 contact info |
EL (ATHENS) | participant | 40˙000.00 |
| 8 |
European Lung Foundation
Organization address
address: Glossop Road 442 contact info |
UK (Sheffield) | participant | 34˙000.00 |
| 9 |
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM
Organization address
address: 's Gravendijkwal 230 contact info |
NL (ROTTERDAM) | participant | 0.00 |
| 10 |
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT LTD.
Organization address
address: Great West Road contact info |
UK (BRENTFORD) | participant | 0.00 |
| 11 |
NOVARTIS PHARMA AG
Organization address
address: LICHTSTRASSE 35 contact info |
CH (BASEL) | participant | 0.00 |
| 12 |
SCHWEIZERISCHES FORSCHUNGSINSTITUT FUER HOCHGEBIRGSKLIMA UND MEDIZIN IN DAVOS
Organization address
address: Promenade 35 contact info |
CH (DAVOS PLATZ) | participant | 0.00 |
| 13 |
UNIVERSYTET MEDYCZNY W LODZI.
Organization address
address: Al. Kosciuszki, 4 contact info |
PL (LODZ) | participant | 0.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'Europe has 30 million people with asthma, whose treatment costs about €20 bn annually. Productivity lost through poor asthma control in Europe is estimated to be €9.8 bn per year. By 2020 approximately 120,000 people in Europe will die from asthma attacks, and 4 million hospitalisations will be needed for the most severely affected. The Objectives of EARIP (European Asthma Research and Innovation Partnership) include to: • reduce the annual level of deaths by 25% within 10 years and 50% within 20 years, and hospitalisations by 50% • identify more effective mechanisms to discover, develop and prioritise biological targets to helping pharmaceutical companies reduce asthma attacks and hospital admissions in asthma of varying severity and mechanistic sub-type • develop new systems, models and tools for the phenotypic stratification of asthma, and determine priority needs of sub-groups • identify innovations needed in health and care systems to put individual patients at the heart of asthma management/treatment, and improve outcomes with better diagnostic and patient self-management plans • review research gaps in treatment of asthma identified at national and international levels, and rank in priority order • identify and internationally ratify a list of research objectives of greatest potential added value in the treatment and management of asthma and produce a Roadmap setting out priorities for the research and innovations needed • address the fragmentation of research approaches and healthcare systems in the management of asthma that has resulted in European countries being 14 of the world's worst 20 for prevalence of asthma in adults, and bring together European stakeholders who will together to address specific Objectives, and review how best to establish a European Innovation Partnership, its Vision, Strategic Priorities, Priority Actions, representative core membership, organisational and governance structure, and requirements for wider interactions'